National Cancer Institute (NCI): Clinical Trials & Research Profile
Federal / NIH (Bethesda, MD) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Federal / NIH (Bethesda, MD) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 318 active (143 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 458 (233 with California sites) |
| Completed vs Early-Stopped Studies | 52 completed / 88 stopped (19.2% stop rate) |
| Median Closed Enrollment | 23 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 100.0% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk